FI972684A0 - Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina - Google Patents

Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina

Info

Publication number
FI972684A0
FI972684A0 FI972684A FI972684A FI972684A0 FI 972684 A0 FI972684 A0 FI 972684A0 FI 972684 A FI972684 A FI 972684A FI 972684 A FI972684 A FI 972684A FI 972684 A0 FI972684 A0 FI 972684A0
Authority
FI
Finland
Prior art keywords
piperidinetic
acid derivatives
fibrinogen antagonists
fibrinogen
antagonists
Prior art date
Application number
FI972684A
Other languages
English (en)
Swedish (sv)
Other versions
FI972684A (fi
Inventor
David George Allen
Colin David Eldred
William Leonard Mitchell
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9426231.8A external-priority patent/GB9426231D0/en
Priority claimed from GBGB9503133.2A external-priority patent/GB9503133D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI972684A0 publication Critical patent/FI972684A0/fi
Publication of FI972684A publication Critical patent/FI972684A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
FI972684A 1994-12-23 1997-06-19 Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina FI972684A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9426231.8A GB9426231D0 (en) 1994-12-23 1994-12-23 Chemical compounds
GBGB9503133.2A GB9503133D0 (en) 1995-02-17 1995-02-17 Chemical compounds
PCT/EP1995/005043 WO1996020192A1 (en) 1994-12-23 1995-12-21 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent

Publications (2)

Publication Number Publication Date
FI972684A0 true FI972684A0 (fi) 1997-06-19
FI972684A FI972684A (fi) 1997-06-19

Family

ID=26306268

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972684A FI972684A (fi) 1994-12-23 1997-06-19 Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina

Country Status (21)

Country Link
US (1) US5861414A (fi)
EP (1) EP0799223B1 (fi)
JP (1) JPH10511375A (fi)
CN (1) CN1175254A (fi)
AP (1) AP9701010A0 (fi)
AR (1) AR002260A1 (fi)
AT (1) ATE181071T1 (fi)
AU (1) AU704496B2 (fi)
CO (1) CO4700291A1 (fi)
DE (1) DE69510228T2 (fi)
DK (1) DK0799223T3 (fi)
ES (1) ES2132761T3 (fi)
FI (1) FI972684A (fi)
GR (1) GR3031027T3 (fi)
IL (1) IL116480A0 (fi)
NO (1) NO972887L (fi)
NZ (1) NZ298400A (fi)
PE (1) PE63696A1 (fi)
SI (1) SI0799223T1 (fi)
WO (1) WO1996020192A1 (fi)
ZA (1) ZA951822B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5760028A (en) * 1995-12-22 1998-06-02 The Dupont Merck Pharmaceutical Company Integrin receptor antagonists
GB9613096D0 (en) * 1996-06-21 1996-08-28 Glaxo Group Ltd Medicaments
ATE431347T1 (de) * 1996-10-14 2009-05-15 Bayer Healthcare Ag Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen
WO1998043962A1 (en) * 1997-03-28 1998-10-08 Du Pont Pharmaceuticals Company Heterocyclic integrin inhibitor prodrugs
US7141581B2 (en) * 1999-07-02 2006-11-28 Agouron Pharmaceuticals, Inc. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
TWI262914B (en) * 1999-07-02 2006-10-01 Agouron Pharma Compounds and pharmaceutical compositions for inhibiting protein kinases
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HUP0400684A2 (hu) * 2000-12-22 2004-07-28 Wyeth 5-Hidroxitriptamin-6-ligandumként használható heterociklilindazol- és -azaindazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
US7008953B2 (en) 2003-07-30 2006-03-07 Agouron Pharmaceuticals, Inc. 3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
GB0400895D0 (en) * 2004-01-15 2004-02-18 Smithkline Beecham Corp Chemical compounds
AR050253A1 (es) * 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681382A (en) * 1969-02-07 1972-08-01 Ciba Geigy Corp 3-aminoindazoles
TW221996B (fi) * 1991-11-14 1994-04-01 Glaxo Group Ltd
US5219867A (en) * 1991-12-16 1993-06-15 Research Corporation Technologies, Inc. Platelet aggregation inhibitory agents
JPH05255308A (ja) * 1992-03-11 1993-10-05 Ajinomoto Co Inc ピペリジン誘導体
JP3194777B2 (ja) * 1992-03-13 2001-08-06 学校法人東京薬科大学 立体選択的ｄ−リボフラノシル化法
JPH06234633A (ja) * 1993-02-10 1994-08-23 Ajinomoto Co Inc アミン誘導体およびこれを含有する抗血小板剤

Also Published As

Publication number Publication date
ZA951822B (en) 1996-09-26
EP0799223B1 (en) 1999-06-09
NO972887L (no) 1997-08-20
AR002260A1 (es) 1998-03-11
DK0799223T3 (da) 1999-12-27
AP9701010A0 (en) 1997-07-31
DE69510228D1 (de) 1999-07-15
NZ298400A (en) 1999-10-28
EP0799223A1 (en) 1997-10-08
CN1175254A (zh) 1998-03-04
PE63696A1 (es) 1997-01-11
ES2132761T3 (es) 1999-08-16
AU704496B2 (en) 1999-04-22
NO972887D0 (no) 1997-06-20
WO1996020192A1 (en) 1996-07-04
SI0799223T1 (en) 1999-10-31
US5861414A (en) 1999-01-19
DE69510228T2 (de) 1999-11-04
FI972684A (fi) 1997-06-19
AU4387896A (en) 1996-07-19
IL116480A0 (en) 1996-03-31
JPH10511375A (ja) 1998-11-04
GR3031027T3 (en) 1999-12-31
CO4700291A1 (es) 1998-12-29
ATE181071T1 (de) 1999-06-15

Similar Documents

Publication Publication Date Title
DE69703385T2 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
DE69308010D1 (de) Sauere wässrige Reinigerzusammensetzungen
ATE269861T1 (de) Substituierte indolalkansäure
NO20006115L (no) Nytt 3-aryl-2-hydroksypropionsyrederivat (I)
DK0560268T3 (da) Substituerede pipecolinsyrederivater som HIV-proteasehæmmere
ATE206931T1 (de) Waessrige risperidone-zusammensetzungen
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
FI972684A0 (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeniantagonisteina
DK0561948T3 (da) Phosphonsyrederivater, der kan anvendes som antiinflammatoriske midler
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
FI953916A0 (fi) Fibrinogeenireseptoriantagonisteja
NO20003965D0 (no) Nye dihydroksyheksansyre-derivater
NO962717D0 (no) Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
DE69801941D1 (de) Kautschukzusammensetzungen welche o-Salicylsalicylicsäure enthalten
FI964342A (fi) Halogeenimetyyliamideja IL-1beta-proteaasi-inhibiittoreina
DK0964863T3 (da) Oxazolidinoner som 5-HT2A-antagonister
NO20003105D0 (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
NO992066D0 (no) Piperazinoderivater som neurokininantagonister
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
NO20011654D0 (no) Benzamidderivater som trombininhibitorer
DK0882044T3 (da) 1,4-dihydropyridinforbindelser som bradykinin-antagonister